Growth Suppression of Friend Virus-transformed Erythroleukemia Cells by P53 Protein is Accompanied by Hemoglobin Production and is Sensitive to Erythropoietin

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 1993 Mar 1

PMID 8441390

Citations 38

Authors

P Johnson

S Chung

S Benchimol

Affiliations

Soon will be listed here.

Abstract

The murine allele temperature-sensitive (ts) p53Val-135 encodes a ts p53 protein that behaves as a mutant polypeptide at 37 degrees C and as a wild-type polypeptide at 32 degrees C. This ts allele was introduced into the p53 nonproducer Friend erythroleukemia cell line DP16-1. The DP16-1 cell line was derived from the spleen cells of a mouse infected with the polycythemia strain of Friend virus, and like other erythroleukemia cell lines transformed by this virus, it grows independently of erythropoietin, likely because of expression of the viral gp55 protein which binds to and activates the erythropoietin receptor. When incubated at 32 degrees C, DP16-1 cells expressing ts p53Val-135 protein, arrested in the G0/G1 phase of the cell cycle, rapidly lost viability and expressed hemoglobin, a marker of erythroid differentiation. Erythropoietin had a striking effect on p53Val-135-expressing cells at 32 degrees C by prolonging their survival and diminishing the extent of hemoglobin production. This response to erythropoietin was not accompanied by down-regulation of viral gp55 protein.

Citing Articles

Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity.

Dittmer U, Sutter K, Kassiotis G, Zelinskyy G, Banki Z, Stoiber H FEMS Microbiol Rev. 2019; 43(5):435-456.

PMID: 31087035 PMC: 6735856. DOI: 10.1093/femsre/fuz012.

Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells.

Pham T, Ma W, Miller D, Kazakova L, Benchimol S Cell Death Dis. 2019; 10(1):22.

PMID: 30622244 PMC: 6325163. DOI: 10.1038/s41419-018-1274-6.

How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?.

Aubrey B, Kelly G, Janic A, Herold M, Strasser A Cell Death Differ. 2017; 25(1):104-113.

PMID: 29149101 PMC: 5729529. DOI: 10.1038/cdd.2017.169.

Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins.

Nelson D, Randle S, Laman H Open Biol. 2013; 3(10):130131.

PMID: 24107298 PMC: 3814724. DOI: 10.1098/rsob.130131.

p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome.

Spike B, Wahl G Genes Cancer. 2011; 2(4):404-19.

PMID: 21779509 PMC: 3135646. DOI: 10.1177/1947601911410224.

References

Mercer W, Shields M, Amin M, Sauve G, Appella E, Romano J . Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci U S A. 1990; 87(16):6166-70. PMC: 54493. DOI: 10.1073/pnas.87.16.6166. View

Donehower L, Harvey M, Slagle B, McArthur M, Montgomery Jr C, Butel J . Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992; 356(6366):215-21. DOI: 10.1038/356215a0. View

DAndrea A, Zon L . Erythropoietin receptor. Subunit structure and activation. J Clin Invest. 1990; 86(3):681-7. PMC: 296781. DOI: 10.1172/JCI114763. View

Diller L, Kassel J, Nelson C, Gryka M, Litwak G, Gebhardt M . p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol. 1990; 10(11):5772-81. PMC: 361354. DOI: 10.1128/mcb.10.11.5772-5781.1990. View

Hoatlin M, Kozak S, Lilly F, Chakraborti A, Kozak C, Kabat D . Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene. Proc Natl Acad Sci U S A. 1990; 87(24):9985-9. PMC: 55299. DOI: 10.1073/pnas.87.24.9985. View

Johnson P, Gray D, Mowat M, Benchimol S . Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells. Mol Cell Biol. 1991; 11(1):1-11. PMC: 359576. DOI: 10.1128/mcb.11.1.1-11.1991. View

Ginsberg D, Oren M . Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein. Mol Cell Biol. 1991; 11(1):582-5. PMC: 359675. DOI: 10.1128/mcb.11.1.582-585.1991. View

Chen P, Chen Y, Bookstein R, Lee W . Genetic mechanisms of tumor suppression by the human p53 gene. Science. 1990; 250(4987):1576-80. DOI: 10.1126/science.2274789. View

Krantz S . Erythropoietin. Blood. 1991; 77(3):419-34. View

10.

Georgoff I, Martinez J, Levine A . Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 1991; 5(2):151-9. DOI: 10.1101/gad.5.2.151. View

11.

Hollstein M, Sidransky D, Vogelstein B, Harris C . p53 mutations in human cancers. Science. 1991; 253(5015):49-53. DOI: 10.1126/science.1905840. View

12.

Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M . Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 1991; 352(6333):345-7. DOI: 10.1038/352345a0. View

13.

Santhanam U, Ray A, Sehgal P . Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A. 1991; 88(17):7605-9. PMC: 52350. DOI: 10.1073/pnas.88.17.7605. View

14.

Ben-David Y, Bernstein A . Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell. 1991; 66(5):831-4. DOI: 10.1016/0092-8674(91)90428-2. View

15.

Shaulsky G, Goldfinger N, Peled A, Rotter V . Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc Natl Acad Sci U S A. 1991; 88(20):8982-6. PMC: 52635. DOI: 10.1073/pnas.88.20.8982. View

16.

Gusella J, Geller R, Clarke B, Weeks V, Housman D . Commitment to erythroid differentiation by friend erythroleukemia cells: a stochastic analysis. Cell. 1976; 9(2):221-9. DOI: 10.1016/0092-8674(76)90113-6. View

17.

Terada M, Fried J, Nudel U, Rifkind R, Marks P . Transient inhibition of initiation of S-phase associated with dimethyl sulfoxide induction of murine erythroleukemia cells to erythroid differentiation. Proc Natl Acad Sci U S A. 1977; 74(1):248-52. PMC: 393236. DOI: 10.1073/pnas.74.1.248. View

18.

Marks P, Rifkind R . Erythroleukemic differentiation. Annu Rev Biochem. 1978; 47:419-48. DOI: 10.1146/annurev.bi.47.070178.002223. View

19.

Caron de Fromentel C, Soussi T . TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer. 1992; 4(1):1-15. DOI: 10.1002/gcc.2870040102. View

20.

Lane D . Cancer. p53, guardian of the genome. Nature. 1992; 358(6381):15-6. DOI: 10.1038/358015a0. View